Y.ora Vision Launches Following Licensing Agreement Between SERI And Eyexora Global To Advance Minimally Invasive Glaucoma Surgery
SINGAPORE, Oct 17 (Bernama-BUSINESS WIRE) — Y.ora Vision, Inc., a new ophthalmic medical device company and spoke company of Eyexora, today announced the signing of a licensing agreement between the Singapore Eye Research Institute (SERI) and Eyexora Global to advance a minimally invasive surgical device for the treatment of mild-to-severe open-angle…

